The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of afatinib administered in a window pre-operative study in squamous cell carcinoma of the head and neck (SCCHN) : EORTC-90111.
 
Jean-Pascal H. Machiels
Consulting or Advisory Role - Boehringer Ingelheim; Merck Sharp & Dohme; Pfizer
Research Funding - Bayer; Janssen; Novartis; Sanofi
 
Jessica Menis
No Relationships to Disclose
 
Michela Lia
No Relationships to Disclose
 
Catherine Fortpied
No Relationships to Disclose
 
Renaud Lhommel
No Relationships to Disclose
 
Marc Lemort
Consulting or Advisory Role - Guerbet
 
Marco Guzzo
No Relationships to Disclose
 
Roberto Bianchi
No Relationships to Disclose
 
Flavio Crippa
No Relationships to Disclose
 
Pasquale Quattrone
No Relationships to Disclose
 
Paolo Bossi
Honoraria - MSD Oncology; Prostrakan; Roche
Consulting or Advisory Role - Helsinn Therapeutics; Merck Serono; Mundipharma; Onxeo
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Helsinn Therapeutics (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
 
Sandra Schmitz
No Relationships to Disclose
 
Thierry Duprez
No Relationships to Disclose
 
Yassine Lalami
No Relationships to Disclose
 
Marie Quiriny
No Relationships to Disclose
 
Nicolas de Saint Aubain
No Relationships to Disclose
 
Paul M. Clement
Research Funding - MSD (Inst)
Expert Testimony - Merck
 
Ruxandra Coropciuc
No Relationships to Disclose
 
Esther Hauben
No Relationships to Disclose
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Debiopharm Group; Eisai; GlaxoSmithKline; Merck Serono; MSD; Novartis; SOBI; VentiRx
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Celgene; Debiopharm Group; Merck Serono; MSD; sobi